US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 13.130
  • +0.780+6.32%
Trading Jan 6 10:27 ET
1.11BMarket Cap-25.25P/E (TTM)

Anavex Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-12.47%132.19M
-12.47%132.19M
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-Cash and cash equivalents
-12.47%132.19M
-12.47%132.19M
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
Receivables
-9.60%2.45M
-9.60%2.45M
-20.56%1.72M
-20.11%3.79M
-13.32%3.55M
-15.16%2.71M
-15.16%2.71M
-66.99%2.17M
-26.76%4.74M
-23.78%4.09M
-Taxes receivable
-9.60%2.45M
-9.60%2.45M
-20.56%1.72M
-20.11%3.79M
-13.32%3.55M
-15.16%2.71M
-15.16%2.71M
-66.99%2.17M
-26.76%4.74M
-23.78%4.09M
Other current assets
42.57%931K
42.57%931K
27.96%1.06M
37.00%1.35M
15.31%756K
84.46%653K
84.46%653K
79.14%827.57K
111.31%981.77K
73.51%655.64K
Total current assets
-12.19%135.57M
-12.19%135.57M
-10.31%141.54M
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-12.19%135.57M
-12.19%135.57M
-10.31%141.54M
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
Liabilities
Current liabilities
Payables
122.74%9.63M
122.74%9.63M
-15.65%3.5M
-40.69%3.73M
-18.84%4.29M
12.99%4.32M
12.99%4.32M
32.81%4.15M
138.68%6.28M
14.10%5.29M
-accounts payable
122.74%9.63M
122.74%9.63M
-15.65%3.5M
-40.69%3.73M
-18.84%4.29M
12.99%4.32M
12.99%4.32M
32.81%4.15M
138.68%6.28M
14.10%5.29M
Current accrued expenses
-44.26%3.31M
-44.26%3.31M
25.24%6.3M
-18.39%4.29M
-5.05%5.5M
27.72%5.94M
27.72%5.94M
0.18%5.03M
17.09%5.25M
36.49%5.79M
Current deferred liabilities
-8.18%842K
-8.18%842K
0.03%917K
0.03%917K
0.03%917K
106.53%917K
106.53%917K
106.56%916.76K
106.56%916.76K
106.56%916.76K
Current liabilities
22.10%15.3M
22.10%15.3M
6.32%11.75M
-31.83%9.56M
-5.68%12.5M
22.71%12.53M
22.71%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
22.10%15.3M
22.10%15.3M
6.32%11.75M
-31.83%9.56M
-5.68%12.5M
22.71%12.53M
22.71%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
Shareholders'equity
Share capital
3.66%85K
3.66%85K
4.43%85K
4.69%84K
5.08%82K
5.13%82K
5.13%82K
4.42%81.39K
3.98%80.24K
2.46%78.03K
-common stock
3.66%85K
3.66%85K
4.43%85K
4.69%84K
5.08%82K
5.13%82K
5.13%82K
4.42%81.39K
3.98%80.24K
2.46%78.03K
-Preferred stock
----
----
----
----
----
----
----
----
--0
----
Retained earnings
-14.67%-336.07M
-14.67%-336.07M
-14.68%-324.45M
-14.94%-312.24M
-16.69%-301.69M
-19.35%-293.07M
-19.35%-293.07M
-22.33%-282.92M
-24.09%-271.64M
-24.02%-258.54M
Paid-in capital
4.92%456.25M
4.92%456.25M
5.74%454.24M
7.35%447.35M
11.08%437.18M
12.08%434.84M
12.08%434.84M
12.48%429.6M
12.19%416.73M
10.94%393.58M
Other equity interest
----
----
---89K
---234K
----
----
----
----
----
----
Total stockholders'equity
-15.22%120.26M
-15.22%120.26M
-11.57%129.78M
-7.03%134.96M
0.33%135.58M
-0.45%141.85M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
Total equity
-15.22%120.26M
-15.22%120.26M
-11.57%129.78M
-7.03%134.96M
0.33%135.58M
-0.45%141.85M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -12.47%132.19M-12.47%132.19M-10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M
-Cash and cash equivalents -12.47%132.19M-12.47%132.19M-10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M
Receivables -9.60%2.45M-9.60%2.45M-20.56%1.72M-20.11%3.79M-13.32%3.55M-15.16%2.71M-15.16%2.71M-66.99%2.17M-26.76%4.74M-23.78%4.09M
-Taxes receivable -9.60%2.45M-9.60%2.45M-20.56%1.72M-20.11%3.79M-13.32%3.55M-15.16%2.71M-15.16%2.71M-66.99%2.17M-26.76%4.74M-23.78%4.09M
Other current assets 42.57%931K42.57%931K27.96%1.06M37.00%1.35M15.31%756K84.46%653K84.46%653K79.14%827.57K111.31%981.77K73.51%655.64K
Total current assets -12.19%135.57M-12.19%135.57M-10.31%141.54M-9.22%144.52M-0.20%148.07M1.10%154.39M1.10%154.39M-1.50%157.81M-0.68%159.19M-5.43%148.37M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -12.19%135.57M-12.19%135.57M-10.31%141.54M-9.22%144.52M-0.20%148.07M1.10%154.39M1.10%154.39M-1.50%157.81M-0.68%159.19M-5.43%148.37M
Liabilities
Current liabilities
Payables 122.74%9.63M122.74%9.63M-15.65%3.5M-40.69%3.73M-18.84%4.29M12.99%4.32M12.99%4.32M32.81%4.15M138.68%6.28M14.10%5.29M
-accounts payable 122.74%9.63M122.74%9.63M-15.65%3.5M-40.69%3.73M-18.84%4.29M12.99%4.32M12.99%4.32M32.81%4.15M138.68%6.28M14.10%5.29M
Current accrued expenses -44.26%3.31M-44.26%3.31M25.24%6.3M-18.39%4.29M-5.05%5.5M27.72%5.94M27.72%5.94M0.18%5.03M17.09%5.25M36.49%5.79M
Current deferred liabilities -8.18%842K-8.18%842K0.03%917K0.03%917K0.03%917K106.53%917K106.53%917K106.56%916.76K106.56%916.76K106.56%916.76K
Current liabilities 22.10%15.3M22.10%15.3M6.32%11.75M-31.83%9.56M-5.68%12.5M22.71%12.53M22.71%12.53M16.56%11.06M73.72%14.02M25.83%13.25M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 22.10%15.3M22.10%15.3M6.32%11.75M-31.83%9.56M-5.68%12.5M22.71%12.53M22.71%12.53M16.56%11.06M73.72%14.02M25.83%13.25M
Shareholders'equity
Share capital 3.66%85K3.66%85K4.43%85K4.69%84K5.08%82K5.13%82K5.13%82K4.42%81.39K3.98%80.24K2.46%78.03K
-common stock 3.66%85K3.66%85K4.43%85K4.69%84K5.08%82K5.13%82K5.13%82K4.42%81.39K3.98%80.24K2.46%78.03K
-Preferred stock ----------------------------------0----
Retained earnings -14.67%-336.07M-14.67%-336.07M-14.68%-324.45M-14.94%-312.24M-16.69%-301.69M-19.35%-293.07M-19.35%-293.07M-22.33%-282.92M-24.09%-271.64M-24.02%-258.54M
Paid-in capital 4.92%456.25M4.92%456.25M5.74%454.24M7.35%447.35M11.08%437.18M12.08%434.84M12.08%434.84M12.48%429.6M12.19%416.73M10.94%393.58M
Other equity interest -----------89K---234K------------------------
Total stockholders'equity -15.22%120.26M-15.22%120.26M-11.57%129.78M-7.03%134.96M0.33%135.58M-0.45%141.85M-0.45%141.85M-2.64%146.75M-4.63%145.17M-7.68%135.12M
Total equity -15.22%120.26M-15.22%120.26M-11.57%129.78M-7.03%134.96M0.33%135.58M-0.45%141.85M-0.45%141.85M-2.64%146.75M-4.63%145.17M-7.68%135.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Heat List
US
Overall
Symbol
Price
% Chg

No Data